Objective-Atrial fibrillation (AF) and atherosclerotic vascular disease are closely entangled disorders and often coexist.
A trial fibrillation (AF) is associated with a high burden of disease, 1 frequently complicates heart failure, 2 and accounts for a quarter of ischemic strokes. 3 Prevalence of AF is on the rise, 4 and healthcare expenditures are expected to increase substantially during the coming years. 5 Rigorous primary prevention programs are mandatory to counteract these threatening trends, and they rely on the identification of modifiable risk factors for AF as potential targets for intervention. Several lines of evidence suggest atherosclerosis to be of relevance both to the evolution and clinical course of AF. A number of studies have reported an association of AF with coronary atherosclerosis and myocardial infarction, 6, 7 and the Rotterdam Study suggests an association with extracoronary (systemic) atherosclerosis as well. 8 Moreover, in patients with AF, presence of atherosclerotic vascular disease was proposed to amplify the risk for thromboembolic stroke and vascular death. [9] [10] [11] This excess risk may derive from more prominent atrial abnormalities or additive effects of AF and atherosclerotic vascular disease on thrombosis susceptibility and systemic inflammation. 9 The aim of the present study was to further scrutinize the association between atherosclerosis and incident AF using data from a prospective population-based study with a 20-year follow-up, thorough ascertainment of AF, and repeated quantification of atherosclerosis.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results
At study baseline, 32 of 932 subjects had a diagnosis of AF and were excluded from the following analyses. Among the remaining 900 individuals, mean age was 58.4 years, 442 (49.1%) were female, and 370 subjects (41.1%) had atherosclerotic lesions at the carotid arteries. During a median follow-up of 20 years, 118 participants developed AFcorresponding to an incidence rate of 8.1 per 1000 personyears (95% confidence interval [CI], 6.8-9.6). The age-and sex-specific incidence rates of AF obtained in our study are in agreement with those observed in other population studies 7,12-15 ( Figure I in the online-only Data Supplement). Subjects with incident AF were older, more likely to have hypertension, show symptoms suggestive of chronic heart failure, and had higher levels of blood pressure, vascular cell adhesion molecule-1, and thyroxine. Baseline population characteristics according to incident AF and carotid atherosclerosis status are depicted in Table 1 and in Table I in  the online-only Data Supplement, respectively. Of note, 27 of the 32 men and women with baseline AF (84.4%) exhibited carotid atherosclerosis, and detection of carotid atherosclerosis antedated the diagnosis of AF in a majority of incident cases (96 of 118). In line with previous evaluations, carotid plaques in the Bruneck Study qualified as a valid surrogate of atherosclerosis in other vascular territories with an overlap as high as 82.1% to the femoral arteries and 73.2% to the abdominal aorta (fourth follow-up in 2010). Aortic diameter and plaque burden (presence of plaques in the infrarenal segment of the aorta) were higher in the case of an AF diagnosis (P=0.028 and P=0.001, fourth follow-up in 2010).
In pooled logistic regression analysis adjusted for age and sex, carotid atherosclerosis emerged as a significant predictor of new-onset AF (odds ratio, 2.0; 95% CI, 1.2-3.3; P=0.011; Table 2 ). This finding was robust in multivariable analysis additionally controlling for level of soluble vascular cell adhesion molecule-1, symptoms of heart failure, and hypertension (odds ratio, 1.8; 95% CI, 1.1-3.1; P=0.021) and in a number of sensitivity analyses (sex-specific analyses, extended adjustment, exclusion of subjects with Data are presented separately for those with and without incident atrial fibrillation during follow-up. Data presented are mean±SD or n (%). CCA indicates common carotid artery; HDL, high-density lipoprotein; IMT, intima-media thickness-this variable was not available at the 1990 baseline; LDL, low-density lipoprotein; NYHA, New York Heart Association classes 1-4 vs 0; tT4, total thyroxine level; and VCAM-1, vascular cell adhesion molecule-1.
*Median (interquartile range) is given for highly skewed variables.
previous myocardial infarction; Table 2 ). Remarkably, odds ratios obtained for atherosclerosis were similar to those calculated for hypertension (multivariable odds ratio, 1.8; 95% CI, 1.1-3.0). Next, we fitted multistate proportional hazards models allowing for a separate focus on subjects with baseline atherosclerosis (1990, prevalent atherosclerosis) and those who developed carotid plaques during follow-up (1990-2010, incident atherosclerosis), and obtained comparable risk estimates in both groups (hazard ratio, 2.5; 95% CI, 1.0-6.6 and hazard ratio, 2.7; 95% CI, 1.0-7.5, respectively). Cumulative hazards for AF in women and men with prevalent or incident atherosclerosis and those free of atherosclerosis are shown in Figure 1 . Cumulative incidence plots, also derived from the multistate model, carefully consider the competing risk of death and covered the life-span ≤90 years (Figure 1 ). Cumulative incidence of AF was the lowest in subjects free of atherosclerosis except for the elderly subjects. Lines converged and even crossed at higher ages because of the substantial survival advantage in women and men free of atherosclerosis (ie, this group more commonly survived to prime ages for AF manifestation). Lifetime risk for development of AF at an index age of 50 years ( Figure 1 In a final step, we investigated the potential effect of AF on mortality and used the entire 1990 study population for these purposes (n=932). Again multistate proportional hazards models were fitted as illustrated in Figure 2 . In brief, subjects with both atherosclerosis and AF (baseline and follow-up) were more likely to die than those with either condition alone (P=0.0034) and faced a particularly high risk of death when compared with individuals free of both conditions (hazard ratio, 4.2; 95% CI, 2.6-6.8; P<0.0001). There was, however, no formal interaction observed between atherosclerosis and AF (P for interaction=0.49) with regard to all-cause mortality. Associations did not change substantially after additional adjustment for New York Heart Association categorization and hypertension.
Discussion
In this prospective population-based cohort with repeated high-quality assessment of atherosclerosis during a period of 20 years, both prevalent and incident atherosclerosis were significantly associated with AF risk independently of age and conventional AF risk factors (Table 2; Figure 1 ). A majority of individuals developed AF on an atherosclerosis background, and the strength of association equaled that observed for hypertension. Subjects with both AF and atherosclerosis were significantly more likely to die than those with either condition alone (Figure 2 ), although a significant interaction was not achieved.
Only 2 previous population-based studies have investigated the potential relationship between AF and carotid atherosclerosis and yielded conflicting results. In the Rotterdam Study, prominent carotid atherosclerosis at baseline translated into an enhanced risk of new-onset AF during a mean follow-up of 7.5 years (relative risk, 1.5; 95% CI, 1.1-2.1), especially in men. 8 In contrast, the Cardiovascular Health Study (CHS) failed to obtain a significant association. However, the analysis accommodating carotid plaques was cross-sectional in design. 16 Moreover, the CHS has been criticized for the selfreport of AF diagnosis in half of the study participants. Selfreport critically depends on the individual's memory, attitude, and motivation and is thus open to detection bias.
There are several potential mechanisms underlying the relation between atherosclerosis and AF found in our study and the Rotterdam Study: (1) Carotid atherosclerosis is a valid surrogate of systemic atherosclerosis as shown previously 17 and evident in the Bruneck Study (see above). Presence of atherosclerosis at large arteries including the aorta conveys heightened arterial stiffness and elevated pulse pressure-an index of the pulsatile load on the heart. [18] [19] [20] Both conditions have repeatedly been demonstrated to predispose to the development of AF. [21] [22] [23] The increase in systolic cardiac afterload gives rise to sustained cardiac remodeling involving ventricular hypertrophy, 24 impaired ventricular relaxation, 25 increased intra-atrial pressure, left atrial dysfunction, and, finally, enlargement. 26 Potential consequences are atrial fibrosis, microvascular damage, and electric remodeling. [27] [28] [29] (2) As an alternative mechanism, atherosclerosis in the coronary arteries may directly cause ischemia or transitory hypoperfusion in the atrium, resulting in fibrosis and occurrence of AF. 27, 30, 31 An excess Odds ratios (95% confidence intervals) were derived from pooled logistic regression analysis applying 5-year intervals (1990-1995, 1995-2000, 2000-2005, and 2005-2010) and an update of covariate levels every 5 years. The main analysis disposed of 3072 observation periods. CI indicates confidence interval.
*Adjusted for age, sex, hypertension, log e -transformed soluble vascular cell adhesion molecule-1, and symptoms suggestive of heart failure (New York Heart Association classes 1-4 vs 0). These variables were selected by a forward stepwise selection procedure (P entry and P removal , 0.05 and 0.10, respectively). Separate models were fitted for men (observation periods, 1503), women (observation periods, 1569), and in subjects without previous myocardial infarction (update every 5 years; observation periods, 2990). †These models were additionally adjusted for self-reported maximum body weight, creatinine level, log e -transformed C-reactive protein, current smoking (0 vs 1), alcohol consumption (gram/d), diabetes mellitus (0 vs 1), pulse pressure, and total thyroxine level.
burden of obstructive coronary artery disease is well founded in patients with AF. 32 In a recent study, half of the patients with idiopathic AF showed coronary artery disease in computed tomography angiography. 33 In a case series of 100 consecutive patients with AF coming to autopsy, 9 cases had a stenosis or occlusion of the nodal artery, and in half of the cases, there was no other coronary pathology. 34 An experimental study in dogs demonstrated that atrial ischemia significantly slows atrial conduction velocity and facilitates maintenance of AF. 35 It has to be emphasized here that causality, although appealing and plausible (see above), cannot be inferred from our epidemiological study. Also, we cannot rule out that the association between atherosclerosis and AF originates from shared pathomechanisms. This scenario, however, is unlikely given the adjustment for a large number of candidate risk factors in our study and the repeated assessment of these factors allowing the performing of a continuous update of expression levels.
The present study has notable strengths including the use of a well-characterized population-based cohort with nearcomplete participation (>90%), the prospective design, the long-term follow-up of 20 years, rigorous analytic methodology (multistate competing risks models), and high-quality ascertainment of atherosclerosis and risk factors. A potential limitation is the sample size, which is sufficient for the key analysis but does not allow scrutinizing the potential effects of atherosclerosis plus AF on stroke risk. Moreover, it is not feasible to capture all cases of AF in prospective population studies. Especially, asymptomatic individuals with rare episodes of paroxysmal AF may escape a proper diagnosis. Finally, we used a definition of heart failure less stringent than that usually applied resulting in rather high prevalence rates. Cumulative hazard of atrial fibrillation (AF) and cumulative incidence of atrial fibrillation by atherosclerosis status and sex, estimated under consideration of the competing risk of death. Top, Prevalent and incident atherosclerosis entailed a similar and significantly elevated hazard of AF. Bottom, The cumulative incidence of AF is a function of both AF hazard and mortality. Therefore, AF incidence curves do not exactly correspond to the AF hazard curves. In particular, the risk of death was substantially increased in subjects with prevalent atherosclerosis, which markedly reduced their lifetime AF incidence simply because they did not survive until manifestation of AF. November 2013
Overall, our study demonstrates a strong and independent association between atherosclerosis and AF but cannot prove causality. Nevertheless, it is appealing to hypothesize that rigorous prevention of atherosclerosis through lifestyle modification and medical therapy could confer benefit in the context of AF both in terms of disease manifestation and prognosis. 
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